A 60-year-old chronic smoker is diagnosed with non-small cell lung cancer based on biopsy. The physician needs to accurately stage the cancer to determine the appropriate treatment plan. Which imaging modality is most crucial for comprehensive staging, including assessment for distant metastases?

Explanation

PET-CT (Positron Emission Tomography-Computed Tomography) is the most crucial imaging modality for comprehensive staging of non-small cell lung cancer. It combines anatomical information from CT with metabolic information from PET, allowing for accurate assessment of the primary tumor, regional lymph node involvement, and detection of distant metastases (e.g., in bone, liver, adrenal glands, and other sites) with high sensitivity and specificity. While HRCT chest is excellent for local tumor and lung parenchyma, and MRI brain/bone scan might be used for specific suspected metastases, PET-CT offers a whole-body assessment for staging, which is essential for determining the extent of disease and guiding treatment decisions.